WuXi Biologics will spend $60 million to build a biologics CDMO plant in Singapore. The facility will be WuXi Biologics’ tenth manufacturing plant globally and the third new facility it has announced in three weeks. Previously, the company released plans to build a $392 million plant in Ireland and then a $240 million facility in the northern China city of Shijiazhuang. During 2011-14, WuXi Biologics opened three large facilities in Shanghai, Wuxi City and Suzhou. When the Singapore plant is up and running, it will provide approximately 150 jobs.
Source: China Biotoday
